Filters

Latest News

2018-09-27 17:57:02

The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing models and multi-sectoral collaboration

New York, 27 September 2018 – As an official UN interlocutor that shares knowledge and expertise to improve global health, ...

Read More

2018-09-26 22:55:14

R&D-based biopharmaceutical industry welcomes UN Declaration on TB Partnerships are key to foster innovation and access

Geneva, 26 September 2018 – Today, at the first-ever United Nations (UN) High-Level Meeting on ...

Read More

2018-09-25 10:21:12

WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines

PR/2018/820 Released jointly by WIPO and IFPMA GENEVA, September 25, 2018 – WIPO and the ...

Read More

2018-09-19 16:37:06

Ghana plays host to major African healthcare business integrity and ethics forum

Over a hundred Pharma industry management and healthcare professionals, medical and scientific advisors receive training ...

Read More

2018-05-28 07:13:31

The R&D-based pharmaceutical industry supports the World Health Organization 5-year work plan and welcomes new era on health partnerships

28 May 2018, Geneva – IFPMA, the voice of the biopharmaceutical innovation and health progress ...

Read More

2018-05-25 10:56:58

IFPMA Welcomes Set-Up of New African Medicines Agency

Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of ...

Read More

2018-05-24 10:34:13

International Alliance of Patients’ Organizations joins Fight the Fakes as 36th partner

Thursday, 24th May, Miami – Fight the Fakes is proud to announce that the International ...

Read More

Latest Statement

2018-10-12 14:58:26

R&D biopharmaceutical industry at WHS 2018 urges finding joint solutions to achieve better health outcomes including forging impactful partnerships

Sunday, 14 October 2018, Berlin – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the body accredited by the ...

Read More

2018-10-04 16:50:33

Global Business Coalition - Knowledge Partners of Global Health & Human Resources Knowledge Partnership Issue Statement

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

2018-09-27 17:58:18

R&D-based biopharmaceutical industry welcomes UN Declaration on NCDs

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

2018-09-26 22:55:57

R&D-based biopharmaceutical industry welcomes UN Declaration on TB

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

2018-09-20 10:31:00

68th WHO Regional Committee for Europe: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

2018-08-30 14:17:00

WHO Afro 68 agenda item 12: Status of implementation of the four time-bound commitments on noncommunicable diseases in the Africa region

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

2018-08-30 14:16:42

WHO Afro 68 agenda item 14: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines

Thursday, 24th May, Miami – Fight the Fakes is proud ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

Collaboration is key to improve #GlobalHealthSecurity – and #immunization has a key role in it, too. In our latest… https://t.co/M3C6xvDrxD
2
  @IFPMA
What role do vaccines development programs play in tackling emerging diseases? Case study: #Zika, and how… https://t.co/t0QHLTbKH2
7 21
  @IFPMA
RT @LaetitiaBigger: Public health emergencies encourage collaboration and innovation from the research and the manufacturing community but…
3
  @IFPMA
RT @SustAbility: Our work with @IFPMA on global health progress & universal health coverage in our latest Radar @kate_newbury https://t.co/
1
  @IFPMA
With new #Zika cases reported in India, we look at @TakedaPharma’s efforts to find a solution in partnership with o… https://t.co/yVqYEfuGNw
  @IFPMA